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Introduction
Late gadolinium enhancement (LGE) images by cardio-
vascular magnetic resonance (CMR) display relative dif-
ferences in gadolinium concentration in the myocardium.
There are many factors influencing signal intensity in LGE
images such as: non-linearity between gadolinium con-
centration and signal intensity, inversion time, contrast
dose, renal clearance, and timing of imaging after contrast
injection. While these factors are not typically problem-
atic in infarct imaging, conditions with more subtle
changes in the myocardium can be more difficult to inter-
pret.
Purpose
The specific aim of the study was to acquire quantitative
pixel-wise parametric maps of the extracellular volume
(ECV) fraction in subjects with a range of pathological
and normal conditions. We hypothesized that ECV imag-
ing could quantitatively differentiate between regions of
atypical LGE and normal myocardium.
Methods
Consecutive clinically referred patients (n = 15) were
scanned at 1.5 T (Siemens) with a Modified Look-Locker
Inversion-recovery (MOLLI) sequence acquired before
and at approximately 15 minutes after a 0.15 mmol/kg
bolus of Gd-DTPA. T1 and R1 (1/T1) pixel maps were gen-
erated. DeltaR1 maps (R1 after - R1 before contrast) were
divided by the DeltaR1 value of the LV blood pool and
multiplied by [1-hematocrit], thus yielding a quantitative
pixel map of the ECV fraction ranging from 0-100%.
Results
The normal myocardium had a mean ECV of 26% (n = 15,
range 23-27%). ECV of focal abnormalities included
lipoma, with a lower ECV than normal (n = 1, 8%),
chronic myocardial infarction (n = 2, 45-53%), and non-
ischemic atypical diffuse enhancement (n = 4, 36-53%),
of which one also had a region with atypical confluent
enhancement (n = 1, 82%). The left panel of Figure 1
shows quantitative ECV pixel map images and corre-
sponding LGE images for two patients exhibiting atypical
diffuse enhancement (arrow) and one instance of atypical
confluent enhancement (arrowhead). The right panel of
Figure 1 shows ECV for different abnormalities in patients
with focal findings (circles) and patients with normal
studies (diamonds).
Conclusion
Quantitative extracellular volume imaging is promising
since it showed no overlap between ECV values for nor-
mal and abnormal myocardium. There are many poten-
tial benefits to ECV imaging. It is largely independent of
inversion time, contrast dose, renal clearance, and timing
of imaging after contrast injection. Thus, ECV imaging
offers a potential to quantitatively define normal myocar-
dium and improve confidence when identifying subtle
abnormalities in the myocardial ECV such as atypical
enhancement.
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